Clinical Monitoring Featured Articles
-
Sponsor And CRO Relationships: Time To Grow Up?
12/22/2011
Traditionally, the biopharmaceutical industry has relied heavily on outsourcing R&D trial tasks to CROs that help manage clinical trials. By Graham Bunn, Medidata
-
FDA’s New Guidance On Clinical Monitoring Arrives
9/6/2011
The FDA has released its long awaited update and replacement to the outdated 1988 guidance on clinical monitoring. The draft guidance for industry on Oversight of Clinical Investigations - A Risk Based Approach to Monitoring is early evidence that the findings and recommendations of the Clinical Trials Transformation Initiative (CTTI), FDA's public-private partnership with Duke University among others, are beginning to take hold in practice in the clinical trials domain. By Jacquie Wiebe Mardell
This website uses cookies to ensure you get the best experience on our website. Learn more